Effect of berberine on LPS-induced intestinal epithelial injury and m6A methylation in broilers
- PMID: 40829428
- PMCID: PMC12391687
- DOI: 10.1016/j.psj.2025.105677
Effect of berberine on LPS-induced intestinal epithelial injury and m6A methylation in broilers
Abstract
This study sought to explore the effects of and potential mechanisms underlying berberine (BBR) in lipopolysaccharide (LPS)-induced intestinal epithelium injury in broilers. Ninety 19-day-old male AA broilers were randomly divided into five groups: the negative control group (NC), positive control group (PC), and three treatment groups (T1, T2, and T3). On the 21st day of age, the control group was orally administered saline, the LPS-challenged group was orally administered LPS (3 mg/kg body weight), and the treatment groups were orally administered BBR (6, 12, 18 mg/kg body weight) along with LPS (3 mg/kg body weight). Afterwards, in vitro cell experiments were used for validation. The results revealed that the oral administration of LPS caused intestinal inflammation and cell apoptosis and disrupted the intestinal barrier and function. However, simultaneous administration of high-dose BBR alleviated LPS-induced adverse changes in intestinal morphology and mucosal barrier integrity by decreasing the expression of inflammatory cytokines and apoptotic proteins, increasing the expression of tight junction proteins, and inhibiting LPS-induced increases in m6A methylation and METTL3 expression. Our findings indicated that BBR addition attenuated LPS-induced intestinal epithelium injury by increasing the expression of tight junction proteins and increasing the anti-inflammatory and antiapoptotic capacity of broiler chickens, possibly via coregulating METTL3 protein expression and m6A methylation levels. The research will provide theoretical support for the application of natural alkaloid anti-inflammatory additives in poultry farming.
Keywords: Berberine; Broiler; Intestinal epithelium injury; Intestinal inflammation; Methylation.
Copyright © 2025. Published by Elsevier Inc.
Conflict of interest statement
Disclosures We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, and there is no professional or other personal interest of any nature or kind in any product, service or company that could be construed as influencing the content of this paper.
Figures







References
-
- Beumer J., Clevers H. Cell fate specification and differentiation in the adult mammalian intestine. Nat. Rev. Mol. Cell Biol. 2021;22:39–53. - PubMed
-
- Cai Y., Yu R., Zhang Z., Li D., Yi B., Feng Z., Xu Q. Mettl3/Ythdf2 regulate macrophage inflammation and ROS generation by controlling Pyk2 mRNA stability. Immunol. Lett. 2023;264:64–73. - PubMed
-
- Chen L., Li L., Han Y., Lv B., Zou S., Yu Q. Tong-fu-li-fei decoction exerts a protective effect on intestinal barrier of sepsis in rats through upregulating ZO-1/occludin/claudin-1 expression. J. Pharmacol. Sci. 2020;143:89–96. - PubMed
-
- Cheng D., Wu C., Li Y., Liu Y., Mo J., Fu L., Peng S. METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation. Biochim. Biophys. Acta Gene Regul. Mech. 2022;1865 - PubMed
LinkOut - more resources
Full Text Sources